Literature DB >> 24443074

Tricks for interpreting and making a good report on hydrogen and 13C breath tests.

G D'Angelo1, T A Di Rienzo, F Scaldaferri, F Del Zompo, M Pizzoferrato, L R Lopetuso, L Laterza, G Bruno, V Petito, M C Campanale, V Cesario, F Franceschi, G Cammarota, E Gaetani, A Gasbarrini, V Ojetti.   

Abstract

Breath tests (BT) represent a valid and non-invasive diagnostic tool in many gastroenterological disorders. Their wide diffusion is due to the low cost, simplicity and reproducibility and their common indications include diagnosis of carbohydrate malabsorption, Helicobacter pylori infection, small bowel bacterial overgrowth, gastric emptying time and orocaecal transit time. The review deals with key points on methodology, which would influence the correct interpretation of the test and on a correct report. While a clear guideline is available for lactose and glucose breath tests, no gold standard is available for Sorbitol, Fructose or other H2 BTs. Orocaecal transit time (OCTT) defined as time between assumption of 10 g lactulose and a peak > 10 ppm over the baseline value, is a well-defined breath test. The possible value of lactulose as a diagnostic test for the diagnosis of small bowel bacterial overgrowth is still under debate. Among (13)C breath test, the best and well characterized is represented by the urea breath test. Well-defined protocols are available also for other (13)C tests, although a reimbursement for these tests is still not available. Critical points in breath testing include the patient preparation for test, type of substrate utilized, reading machines, time between when the test is performed and when the test is processed. Another crucial point involves clinical conclusions coming from each test. For example, even if lactulose could be utilized for diagnosing small bowel bacterial overgrowth, this indication should be only secondary to orocaecal transit time, and added into notes, as clinical guidelines are still uncertain.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24443074

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  3 in total

1.  Modification of baseline status to improve breath tests performance.

Authors:  Estibaliz Alegre; Amaia Sandúa; Sofía Calleja; Sara Deza; Álvaro González
Journal:  Sci Rep       Date:  2022-06-13       Impact factor: 4.996

2.  Fructose Malabsorption in Patients With Irritable Bowel Syndrome-like Symptoms: What Is the Role in the Pathogenesis and Clinical Implication?

Authors:  Hye-Young Sung; Yong Sung Kim
Journal:  J Neurogastroenterol Motil       Date:  2014-04-30       Impact factor: 4.924

Review 3.  European guideline on indications, performance, and clinical impact of hydrogen and methane breath tests in adult and pediatric patients: European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Neurogastroenterology and Motility, and European Society for Paediatric Gastroenterology Hepatology and Nutrition consensus.

Authors:  Heinz F Hammer; Mark R Fox; Jutta Keller; Silvia Salvatore; Guido Basilisco; Johann Hammer; Loris Lopetuso; Marc Benninga; Osvaldo Borrelli; Dan Dumitrascu; Bruno Hauser; Laszlo Herszenyi; Radislav Nakov; Daniel Pohl; Nikhil Thapar; Marc Sonyi
Journal:  United European Gastroenterol J       Date:  2021-08-25       Impact factor: 4.623

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.